MetaCap

YD Bio Insider Trades

NASDAQ: YDESHealth CareMedical SpecialitiesUSD

4.83+0.27 (+5.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
3 · $128.53K
Sales
0 · $0
Shares bought / sold
34.18K / 0
Net activity
Net buying $128,525

YD Bio insider activity

Over the last 12 months, YD Bio insiders reported 9 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $128,525 and sold $0 worth of stock, for net insider buying of $128,525. The most recent filing shows Chang Kochi (Director) reporting a transaction in 3,135 shares on Sep 30, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put YDES's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

YDES insider transactions

YD Bio insider transactions
DateInsiderTypeSharesValueFiling
Sep 30, 2026Lu Shao-TaDirectorOption exercise3,135—Form 4
Sep 30, 2026Chang KochiDirectorOption exercise3,135—Form 4
Sep 14, 2026Shen Ethan PhDCEOBuy12,700$48.90KForm 4
Sep 9, 2026Shen Ethan PhDCEOBuy3,100$12.18KForm 4
Sep 4, 2026Shen Ethan PhDCEOBuy18,378$67.45KForm 4
Jun 30, 2026Chang KochiDirectorOption exercise5,749—Form 4
Jun 30, 2026Lu Shao-TaDirectorOption exercise5,749—Form 4
Mar 31, 2026Chang KochiDirectorOption exercise2,081—Form 4
Mar 31, 2026Lu Shao-TaDirectorOption exercise2,081—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related